Skip to content

LivaNova

US · LIVN #2263 by market cap Listed 1970
90.73 -1.34 -1.46%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 11 in the most recent period (2026/Q3).
  • Total institutional ownership rose 3.3 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
117.38% +3.31pp
Institutions
393 +11
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund97.66%
Hedge Fund10.23%
Public Company4.86%
Government Pension Fund1.91%
Insurance Company1.61%
Private Company0.47%
Individual/Insider0.44%
Sovereign Wealth Fund0.31%
Family Office/Trust0.17%

Top holders as of 2026-09-30

BlackRock 14.05% · 7.74M sh
PRIMECAP Management Company 7.57% · 4.17M sh
FMR 7.22% · 3.98M sh
Hood River Capital Management LLC 4.66% · 2.57M sh
AQR Capital Management 4.25% · 2.34M sh
Invesco Ltd. 4.12% · 2.27M sh
Artisan Partners Limited Partnership 4.04% · 2.22M sh
State Street Global Advisors 3.93% · 2.17M sh
American Century Investment Management 3.65% · 2.01M sh
Dimensional Fund Advisors 3.43% · 1.89M sh
Geode Capital Management, LLC 3.19% · 1.76M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 29 buys · 20 sells

NameRoleStake
Alex Shvartsburg Chief Financial Officer 0.08%
William Kozy Chairman of Board 0.07%
Stephanie Bolton President of Global Epilepsy 0.04%
Trui Hebbelinck Former Chief Human Resources Officer 0.03%
Stacy Seng Independent Non-Executive Director 0.03%
Vladimir Makatsaria Chief Executive Officer 0.03%
Todd Schermerhorn Independent Non-Executive Director 0.02%
Sharon O'Kane Former Independent Non-Executive Director 0.02%
Franco Poletti Former President of Cardiopulmonary Business Unit 0.02%
Peter Wilver Independent Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-11 Alex Shvartsburg Chief Financial Officer Automatic Disposition -2,500 $90.91
2026-09-14 Anne Liddy Chief Legal Officer Other Derivative Acquisition +6,291 --
2026-09-09 Francesco Bianchi Independent Non-Executive Director Open Market Disposition -3,500 $78.01
2026-09-03 Brooke Story Independent Director Open Market Disposition -2,300 $81.42
2026-09-01 Franco Poletti Former President of Cardiopulmonary Business Unit Intent to Sell (Form 144) -10,755 $82.09
2026-08-30 Francesco Bianchi Independent Non-Executive Director Open Market Disposition -1,650 $79.72
2026-08-10 Ahmet Tezel Chief Innovation Officer Derivative Exercise and Sale -12,692 $52.68–77.86
2026-06-14 Todd Schermerhorn Independent Non-Executive Director Derivative Exercise and Sale -486 $79.70
2026-06-14 Todd Schermerhorn Independent Non-Executive Director Other Derivative Acquisition +2,383 --
2026-06-14 Todd Schermerhorn Independent Non-Executive Director Derivative Exercise and Retained +3,556 --
2026-06-14 Peter Wilver Independent Director Derivative Exercise and Sale -486 $79.70
2026-06-14 Peter Wilver Independent Director Other Derivative Acquisition +2,383 --
2026-06-14 Peter Wilver Independent Director Derivative Exercise and Retained +3,556 --
2026-06-14 William Kozy Chairman of Board Derivative Exercise and Sale -682 $79.70
2026-06-14 William Kozy Chairman of Board Other Derivative Acquisition +2,383 --
2026-06-14 William Kozy Chairman of Board Derivative Exercise and Retained +4,999 --
2026-06-14 Stacy Seng Independent Non-Executive Director Derivative Exercise and Sale -486 $79.70
2026-06-14 Stacy Seng Independent Non-Executive Director Other Derivative Acquisition +2,383 --
2026-06-14 Stacy Seng Independent Non-Executive Director Derivative Exercise and Retained +3,556 --
2026-06-14 Donald Zurbay Independent Director Derivative Exercise and Sale -308 $79.70

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

LivaNova discussion 0 comments

Add a comment